Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - OPERATING EXPENSES
Operating Expenses NVO - Novo Nordisk A/S
93.9 B
LAST VALUE
26.71%
2 YEAR CAGR
14.87%
5 YEAR CAGR
9.49%
10 YEAR CAGR